Javier Rodriguez Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

Javier Rodriguez is Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 1,591 shares of BTAI, which is worth approximately $3,054. The most recent transaction as insider was on Mar 15, 2025, when has been sold 34 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.59K

93.49% 3M change

79.26% 12M change

Total Value Held $3,054

Javier Rodriguez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2025	BUY Exercise of conversion of derivative security	-	34 Added 2.09%	1,591 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	-	31 Added 1.95%	1,557 Common Stock
Dec 16 2024	SELL Open market or private sale	$154 $0.36 p/Share	430 Reduced 1.73%	24,423 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	562 Added 2.21%	24,853 Common Stock
Dec 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 2.1%	24,291 Common Stock
Oct 03 2024	SELL Open market or private sale	$3,774 $0.55 p/Share	6,863 Reduced 22.4%	23,770 Common Stock
Sep 17 2024	BUY Grant, award, or other acquisition	-	21,250 Added 40.96%	30,633 Common Stock
Sep 16 2024	SELL Open market or private sale	$238 $0.69 p/Share	345 Reduced 3.64%	9,133 Common Stock
Sep 15 2024	BUY Exercise of conversion of derivative security	-	563 Added 5.61%	9,478 Common Stock
Sep 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 5.52%	8,915 Common Stock
Jun 17 2024	SELL Open market or private sale	$454 $1.26 p/Share	361 Reduced 4.12%	8,394 Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	562 Added 6.03%	8,755 Common Stock
Jun 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 5.98%	8,193 Common Stock
Apr 04 2024	SELL Open market or private sale	$2,671 $2.64 p/Share	1,012 Reduced 11.65%	7,672 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 20.58%	8,684 Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 7.49%	6,434 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 8.1%	5,913 Common Stock
Sep 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 8.81%	5,392 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 9.66%	4,871 Common Stock
May 15 2023	SELL Open market or private sale	$48,766 $27.32 p/Share	1,785 Reduced 29.1%	4,350 Common Stock
May 14 2023	BUY Exercise of conversion of derivative security	-	5,000 Added 44.9%	6,135 Common Stock
Mar 15 2023	SELL Open market or private sale	$18,639 $19.62 p/Share	950 Reduced 45.56%	1,135 Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	-	2,084 Added 50.0%	2,084 Common Stock

Javier Rodriguez

Officer

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioXcel Therapeutics, Inc.

Track Activities on BTAI

Account